Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcription factor immunohistochemistry in the diagnosis of pituitary tumours

14 Apr 2021

Abstract excerpt

OBJECTIVE: The clinical utility and prognostic value of WHO 2017 lineage-based classification of pituitary tumours have not been assessed. This study aimed to (1) determine the clinical utility of transcription factor analysis for classification of pituitary tumours and (2) determine the prognostic value of improved lineage-based classification of pituitary tumours. METHODS: This was a retrospective evaluation of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Meningioma and schwannoma management
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33852418
DOI: 10.1530/eje-20-1273

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcription factor immunohistochemistry in the diagnosis of pituitary tumoursPMID 33852418Read ↗

Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO EraSemantic proximity Read ↗

Validation of a Clinicopathological Classification for Predicting Outcomes of Pituitary Tumours: Retrospective Cohort Study in a Pituitary Tumour Centre of Excellence, 2013–2023Semantic proximity Read ↗

A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classificationSemantic proximity Read ↗

How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?Semantic proximity Read ↗

Annotation of pituitary neuroendocrine tumors with genome-wide expression analysisSemantic proximity Read ↗

Machine learning to comprehensively reveal signature genes and regulatory mechanisms in pituitary tumorsSemantic proximity Read ↗

Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor CellsSemantic proximity Read ↗

From Genes to Therapy: Pituitary Adenomas in the Era of Precision MedicineSemantic proximity Read ↗

Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNETSemantic proximity Read ↗

Clinical integration and application of the 2022 WHO pituitary tumor classificationSemantic proximity Read ↗

Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.Semantic proximity Read ↗

Splicing diversity enhances the molecular classification of pituitary neuroendocrine tumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.